Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study - ScienceDirect
Dosing and Administration | Repatha® (evolocumab)
Repatha Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
Repatha (Evolocumab) - Amgen.de
Repatha Dosage Guide - Drugs.com
Recommended Dosing of PCSK9 Inhibitors | Download Table
Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of evolocumab between Caucasian and Asian populations - Wang - 2019 - British Journal of Clinical Pharmacology - Wiley Online Library
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial - The Lancet
Model-predicted time course of LDL-C after multiple SC evolocumab doses. | Download Scientific Diagram
PCSK9 inhibitor use during pregnancy in a case of familial hypercholesterolemia complicated with coronary artery disease - Suzuki - Journal of Obstetrics and Gynaecology Research - Wiley Online Library
Abstract 16270: Evaluation of the Relationship Between Evolocumab 140 mg Every Two Weeks and 420 mg Monthly Dosing Regimens | Circulation
Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals | Semantic Scholar
Evolocumab - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor| Amgen
Repatha (evolocumab): Uses, Side Effects, Alternatives & More - GoodRx
How to Take Repatha® (evolocumab) Injection
Repatha: Package Insert - Drugs.com
Repatha: Package Insert - Drugs.com
Repatha ( Evolocumab) Praluent (Arilocumab) - ppt download
Buy Repatha (evolocumab) Online • Price & Costs | Everyone.org
Observed unbound evolocumab concentration-time profiles after single... | Download Scientific Diagram
Evolocumab (Repatha) for the Treatment of Hyperlipidemia | AAFP
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia | Journal of the American College of Cardiology
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor | Clinical Pharmacokinetics
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia - ScienceDirect
